These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21876828)

  • 1. Copper modulation as a therapy for Alzheimer's disease?
    Manso Y; Comes G; Hidalgo J; Bush AI; Adlard PA
    Int J Alzheimers Dis; 2011; 2011():370345. PubMed ID: 21876828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalances in Copper or Zinc Concentrations Trigger Further Trace Metal Dyshomeostasis in Amyloid-Beta Producing
    Metaxas A
    Front Neurosci; 2021; 15():755475. PubMed ID: 34707479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer's Disease Correlates with Metal Levels in the Surrounding Neuropil.
    James SA; Churches QI; de Jonge MD; Birchall IE; Streltsov V; McColl G; Adlard PA; Hare DJ
    ACS Chem Neurosci; 2017 Mar; 8(3):629-637. PubMed ID: 27958708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
    Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ
    Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
    Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
    Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metals and amyloid-beta in Alzheimer's disease.
    Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX
    Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
    Tõugu V; Tiiman A; Palumaa P
    Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloidogenesis induced by diet cholesterol and copper in a model mouse for Alzheimer's disease and protection effects of zinc and fluvastatin.
    Yao D; Jing T; Niu L; Huang X; Wang Y; Deng X; Wang M
    Brain Res Bull; 2018 Oct; 143():1-8. PubMed ID: 30227236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of metals on spatial memory in a transgenic mouse model of Alzheimer's disease.
    Railey AM; Groeber CM; Flinn JM
    J Alzheimers Dis; 2011; 24(2):375-81. PubMed ID: 21239856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-beta metal interaction and metal chelation.
    Cuajungco MP; Frederickson CJ; Bush AI
    Subcell Biochem; 2005; 38():235-54. PubMed ID: 15709482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
    Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
    Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of copper and the copper-related protein CUTA in mediating APP processing and Aβ generation.
    Hou P; Liu G; Zhao Y; Shi Z; Zheng Q; Bu G; Xu H; Zhang YW
    Neurobiol Aging; 2015 Mar; 36(3):1310-5. PubMed ID: 25557959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic redistribution of metal ions to treat Alzheimer's disease.
    Crouch PJ; Barnham KJ
    Acc Chem Res; 2012 Sep; 45(9):1604-11. PubMed ID: 22747493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
    Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
    Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
    Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
    Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation.
    Gallagher JJ; Minogue AM; Lynch MA
    Neurodegener Dis; 2013; 11(1):33-41. PubMed ID: 22627185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.